An expanding retail marketplace means that there are more opportunities for health plans to develop innovative strategies to reach consumers that are entering the market space for the first time. It is essential for health plans to not only engage these consumers but also to assist them in making good healthcare decisions.
An expanding retail marketplace means that there are more opportunities for health plans to develop innovative strategies to reach consumers that are entering the market space for the first time. It is essential for health plans to not only engage these consumers but also to assist them in making good healthcare decisions. On Tuesday, Juan-Pierre Stephan, senior executive, Health CRM, Accenture, spoke about approaches and barriers to effective patient engagement.
The data-heavy presentation began with a number of statistics, including the following:
Accenture initiated studies to determine what exactly all of these statistics could mean for the marketplace. The results provided 4 insights that are key to the success of health insurers:
Part of the problem insurers now face in this evolving landscape is the fact that consumers often define themselves into segments differently than their insurers do. Many insurers use antiquated techniques to segment their populations, and this needs to change in order to succeed in a much different and constantly changing landscape. Unfortunately, Mr. Stephan said, change needs to come from the top. Barriers like fragmented project implementations and a lack of enterprise sponsorship can deter organizations from enacting change that could lead to success in a new marketplace. Additionally, said Mr. Stephan, the influence of employee engagement as a catalyst for change is vastly undervalued at many organizations. However, it is not too late to enact company-wide transformations. If organizations are able to break down the silos, identify core competencies, and align incentives (both internally and externally), they stand to enjoy early and continued success in a highly competitive market.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More